The best practices of the Russian Federation in the organization of anticoagulant therapy in patients with high risk of thromboembolic events
T. V. Vavilova,
L. V. Solovyova,
A. B. Bekoeva,
P. Yu. Zubkova,
N. A. Vorobyeva,
A. I. Vorobyeva,
E. Yu. Melnichuk,
M. V. Khruslov,
N. K. Vereina,
D. D. Safin,
A. S. Galyavich,
M. Sluiter,
G. V. Endubaeva,
E. V. Shlyakhto https://doi.org/10.15829/1560-4071-2020-3945
Abstract
Organization of anticoagulant therapy control plays a key role in ensuring the effectiveness and safety of anticoagulant use. Currently, several models of organization are successfully used in the Russian Federation, which cover more than 23000 patients at high risk for thromboembolic events. There are following common features of the models used: the maximum reduction in the time from the moment of international normalized ratio (INR) testing with a quick communication with a patient for the need to adjust the dose, the ability to sort patients depending on the degree of hypocoagulation and the risks of events with the creation of a personalized approach to treatment, the organization of a shared information space and maintaining a register of patients.
About the Authors
T. V. Vavilova
Almazov National Medical Research Center
Russian Federation
Russian Federation
MD, PhD, doctor of medical sciences, professor, Head of the Department of laboratory medicine and genetics Federal State Budgetary Institution Scientific Research Center named after V.A. Almazova, chief visiting specialist in clinical laboratory diagnostics of the Russian Ministry of Health for the Northwestern federal districts
St. PetersburgL. V. Solovyova
Department of adult ambulatory care organization of the Health Committee of St. Petersburg
Russian Federation
Russian Federation
MD, PhD, Head of the Department for the organization of outpatient medical care for adults of the health committee of the administration of St. Petersburg
St. PetersburgA. B. Bekoeva
City Consultative Diagnostic Center № 1
Russian Federation
Russian Federation
MD, Head of the antithrombotic therapy room
St. Petersburg
P. Yu. Zubkova
Almazov National Medical Research Center
Russian Federation
Russian Federation
MD, Head of the antithrombotic therapy room
St. Petersburg
N. A. Vorobyeva
Northern State Medical University;
Northern branch of National Medical Research Center of Hematology
Russian Federation
Russian Federation
MD, PhD, doctor of medical sciences, professor, Head of the Department of clinical pharmacology and pharmacotherapy Federal State Budgetary Institution Northern State Medical University Ministry of Health of Russia, Head of Federal State Budgetary Institution "National Medical Research Center for Hematology" (Northern branch) Ministry of Health of Russia
ArkhangelskA. I. Vorobyeva
Northern State Medical University
Russian Federation
Russian Federation
MD, researcher central research laboratory
ArkhangelskE. Yu. Melnichuk
Northern State Medical University
MD, assistant of the Department of clinical pharmacology and pharmacotherapy
ArkhangelskM. V. Khruslov
Almazov National Medical Research Center;
Kursk Regional Clinical Hospital
Russian Federation
Russian Federation
MD, PhD, cardiovascular surgeon Kursk Regional Clinical Hospital of the Kursk Region Health Committee, organizer of the centralized monitoring system for anticoagulant therapy in the Kursk region
St. Petersburg, Kursk
N. K. Vereina
South Ural State Medical University
Russian Federation
Russian Federation
MD, PhD, doctor of medical sciences, professor Department of Faculty Therapy
Chelyabinsk
D. D. Safin
Interregional Clinical Diagnostic Center
Russian Federation
Russian Federation
MD, cardiologist of the outpatient department
Kazan
A. S. Galyavich
Kazan State Medical University
Russian Federation
Russian Federation
MD, PhD, doctor of medical sciences, professor, Head of the Department of сardiology, Faculty of Continuing Education and Professional Retraining Kazan State Medical University
KazanM. Sluiter
LLC Portavita Health
Netherlands
Kazan
Netherlands
Kazan
G. V. Endubaeva
Almazov National Medical Research Center
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
E. V. Shlyakhto
Almazov National Medical Research Center
Doctor of medical sciences, professor, Academician of the Russian Academy of Science, Honoured Scientist of Russia, President of the Russian Society of Cardiology, chief visiting cardiologist of the Russian Ministry of Health for the Volga, Southern, North Caucasian and Northwestern federal districts, Director General of Federal State Budgetary Institution Scientific Research Center named after V.A. Almazova» Ministry of Health of Russia
St. PetersburgReferences
1. Damen N. L. , Van den Bemt B.J.F., Hersberger K.E., Papastergiou J., Alves da Costa F., Rydant S., Wartenberg N, S., Lobban T., Arnet I., Antoniou S. on behalf of International Pharmacists for Anticoagulation Care Taskforce (iPACT). Creating an Interprofessional guideline to support patients receiving oral anticoagulation therapy: a Delphi exercise // International Journal of Clinical Pharmacy (2019) 41:1012–1020 https://doi.org/10.1007/s11096-019-00844-0.
2. Hart R.G., Pearce L.A., Aguilar M.I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.Ann Intern Med 2007; 146: 857–867.
3. Barnes G. D., Nallamothu B. K., Sales A. E., and Froehlich J. B. Reimagining Anticoagulation Clinics in the Era of Direct Oral Anticoagulants // Circ Cardiovasc Qual Outcomes. 2016 March ; 9(2): 182–185. doi:10.1161/CIRCOUTCOMES. 115.002366.
4. Barnes GD, Kline-Rogers E, Graves C, Puroll E, Gu X, Townsend K, McMahon E, Craig T, Froehlich JB. Structure and function of anticoagulation clinics in the United States: an AC forum membership survey // J Thromb Thrombolysis. 2018 Jul;46(1):7-11. doi: 10.1007/s11239-018-1652-z.PMID: 29605836
Review
For citations:
Vavilova T.V., Solovyova L.V., Bekoeva A.B., Zubkova P.Yu., Vorobyeva N.A., Vorobyeva A.I., Melnichuk E.Yu., Khruslov M.V., Vereina N.K., Safin D.D., Galyavich A.S., Sluiter M., Endubaeva G.V., Shlyakhto E.V. The best practices of the Russian Federation in the organization of anticoagulant therapy in patients with high risk of thromboembolic events. Russian Journal of Cardiology. 2020;25(6):3945. https://doi.org/10.15829/1560-4071-2020-3945
Views:
1331
Email this article 